Novartis reported a 12% rise in second-quarter net profit as the Swiss pharmaceuticals giant benefited from the recent acquisition of eye care specialist Alcon and solid growth of recently launched drugs.
WSJ.com: What's News US, Wall Street Journal
Mon, 07/18/2011 - 11:24pm
Novartis reported a 12% rise in second-quarter net profit as the Swiss pharmaceuticals giant benefited from the recent acquisition of eye care specialist Alcon and solid growth of recently launched drugs.